CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 80 filers reported holding CYTOSORBENTS CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $80,000 | -7.0% | 10,000 | -23.1% | 0.01% | -37.5% |
| Q2 2019 | $86,000 | -48.8% | 13,000 | 0.0% | 0.01% | -52.9% |
| Q1 2019 | $168,000 | +60.0% | 13,000 | 0.0% | 0.02% | +30.8% |
| Q4 2018 | $105,000 | -37.5% | 13,000 | 0.0% | 0.01% | -23.5% |
| Q3 2018 | $168,000 | +13.5% | 13,000 | 0.0% | 0.02% | +21.4% |
| Q2 2018 | $148,000 | +64.4% | 13,000 | 0.0% | 0.01% | +40.0% |
| Q1 2018 | $90,000 | +5.9% | 13,000 | 0.0% | 0.01% | +11.1% |
| Q4 2017 | $85,000 | +7.6% | 13,000 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $79,000 | +41.1% | 13,000 | 0.0% | 0.01% | +50.0% |
| Q2 2017 | $56,000 | -5.1% | 13,000 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $59,000 | – | 13,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
| Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
| CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
| Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
| Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
| Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
| Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
| SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
| Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |